Public Charge: Chronic Diseases Become Red Flags in US Visas

The U.S. Department of State has issued a directive that redefines how health conditions are assessed in visa and green card processes. Since November 2025, consular officers have been instructed to treat common chronic illnesses, such as diabetes, obesity, cardiovascular diseases, and asthma, as potential risk indicators under the public charge rule. The change affects virtually all visa categories, from tourism to permanent immigration, and requires applicants to be better financially prepared.

The Public Charge Rule

Inadmissibility due to public charge is one of the most consequential grounds under Section 212 of the Immigration and Nationality Act (INA). In practical terms, the rule allows immigration officers to deny a visa or green card to anyone deemed likely to substantially depend on the U.S. government for financial support. The determination takes into account the totality of the applicant’s circumstances: health, finances, family situation, age, education, and work history.

Historically, inadmissibility on health grounds focused on infectious diseases, such as tuberculosis and syphilis, which pose a direct risk to public health. The new directive shifts the focus to non-communicable chronic conditions, assessing them from the perspective of the long-term financial cost to the U.S. healthcare system.

Which Conditions Are Red Flags

The State Department directive is not limited to a closed list, but identifies categories of diseases that will now receive stricter scrutiny at consulates:

• Cardiovascular diseases
• Respiratory diseases (including asthma)
• Cancers
• Diabetes
• Metabolic diseases (including obesity)
• Neurological diseases
• Mental health conditions

The potential reach of this policy is vast. According to the American Heart Association, 48% of adults in the U.S. have some form of cardiovascular disease. The National Institute of Mental Health reports that 23% of American adults experience a mental disorder each year. Applied to visa applicants, these same criteria could affect millions of cases globally.

What Has Changed in Practice

The directive was issued via a consular cable on November 6, 2025, and instructs officers to assess whether chronic conditions could lead to long-term financial dependence on public resources such as Medicaid. The health factor now plays a central role in admissibility decisions, whereas it was previously secondary to financial and professional factors.

The policy applies to all classes of temporary and permanent visas, including B-1/B-2 (tourism and business), H-1B (specialized work), F-1 (students), and family and employment-based immigration petitions. Humanitarian categories, such as refugees and certain special immigrant visas, remain exempt.

How to Prepare

Visa applicants must continue to disclose medical conditions as required by law. The difference now is the need to demonstrate, with robust documentation, the financial ability to cover foreseeable medical expenses without resorting to government assistance.

In family-based immigration cases, the Affidavit of Support (Form I-864) becomes even more important. This document demonstrates that the sponsor has sufficient income to support the beneficiary and prevent reliance on public benefits. Essential financial documentation includes:

• Income tax returns for the past three years
• Current proof of income and employment
• Bank statements and proof of assets
• Private health insurance policies, when applicable
• Evidence of a medical plan for treatment of pre-existing chronic conditions

For applicants with chronic conditions, proactively presenting a private medical coverage plan, documentation of stable employment, and evidence of financial resources can be decisive in overcoming the additional scrutiny imposed by the directive.

Impact on Consular Practice

The directive represents one of the most significant changes in the interpretation of public charge in decades. By including health conditions that affect nearly half of the U.S. population itself, the policy creates a standard of inadmissibility that can be broadly applied to applicants from countries where access to private health insurance with international coverage is less common.

In practice, consular officers now have greater discretion to deny visas based on medical diagnoses that, until now, were not considered relevant factors for inadmissibility. This significantly raises the bar for applicants with any listed chronic condition, even those extremely prevalent in the global population.

Broader Regulatory Context

The November 2025 consular directive is part of a broader regulatory movement. On November 17, 2025, the Department of Homeland Security (DHS) published a Notice of Proposed Rulemaking to revoke the 2022 public charge rule, which had adopted a more restrictive interpretation of the concept. Additionally, on January 21, 2026, the Department of State announced a pause in visa issuance for citizens of 75 countries considered at high risk of becoming a public charge.

Together, these measures signal a trend toward tightening admissibility criteria in U.S. immigration processes. Transparency in preparing documentation and clear demonstration of financial self-sufficiency are the most effective tools for navigating this scenario. Visa and green card applicants should treat medical and financial documentation as complementary and equally strategic components of their immigration processes.

Victoria Harper

Editor-in-Chief

Meet the author

Leading journalism and editorial content at Visto n’ Visa, Victoria helps make immigration topics clear, trustworthy, and easy to understand. Her focus is on delivering useful, human, and relevant content for people exploring new paths abroad.